Delivery Order SPE2DV17D1012-SPE2DV22F69NK
Award Date 6/6/22
Potential Completion Date 6/7/22
Potential Value $3.2K
Federal Agency
Awardee
Ultimate Awardee
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Waukegan, IL 60085, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc. The $1,268.10 firm-fixed-price contract is for the supply of 4562011165 - NDL ENT SEMIPERMANENT INJECTOR NI FR SM. It does not have a set-aside designation. The contract is issued against Cardinal Health 200, LLC's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, contract number SPE2DV, which allows DLA...
- This is a firm fixed-price delivery order contract awarded to Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for 4561391279 - NDL ENT SEMIPERMANENT INJECTOR NI FR SM, with a completion date of July 3, 2023 and a potential value of $2,440.07. Cardinal Health 200, LLC holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, contract number SPE2DV, that allows DLA to rapidly...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc., a major medical products and services company. The contract is for the provision of NDL ENT SEMIPERMANENT INJECTOR NI FR SM medical devices, with a potential value of $1,020.62 and a completion date of April 13, 2023. The contract is an Indefinite Delivery Contract (IDC) vehicle, allowing DLA to rapidly obtain needed medical consumables,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Cardinal Health 200, LLC, a subsidiary of the medical products and services company Cardinal Health, Inc. The contract provides for the delivery of NDL ENT SEMIPERMANENT INJECTOR NI FR SM medical products. The single-award Indefinite Delivery Contract (IDC) SPE2DV with DLA allows the agency to procure up to $5 million worth of medical and pharmaceutical products falling under Federal Supply Group 46 and Federal Supply...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the procurement of 4558058019 - NDL ENT SEMIPERMANENT INJECTOR NI FR SM, with an ultimate completion date of August 31, 2022 and a ceiling value of $1,040.85. This Delivery Order is issued under the existing Indefinite Delivery Contract (IDC) SPE2DM20D6509, valued at up to $4,999,999, which allows DLA to rapidly acquire a wide range of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the delivery of 4563340030 NDL ENT SEMIPERMANENT INJECTOR NI FR SM, a medical device or supply. The contract has a firm fixed price ceiling value of $1,505.71 and a period of performance through February 7, 2024. This delivery order is placed against a larger Indefinite Delivery Contract (IDC) held by Cardinal Health 200, LLC...
- This is a delivery order contract (SPE2DM23FJY42) awarded by the Defense Logistics Agency (DLA) to Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the procurement of 4561984597 ! NDL ENT SEMIPERMANENT INJECTOR NI FR SM medical supplies. The contract has a ceiling value of $2,530.84 and a period of performance through September 20, 2023. This delivery order is issued against an existing Indefinite Delivery Contract (IDC) held by Cardinal Health 200, LLC,...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $1,270.00 to Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the procurement of NDL ENT SEMIPERMANENT INJECTOR NI FR SM. This contract is part of the single-award Indefinite Delivery Contract SPE2DV held by Cardinal Health 200, which allows DLA to rapidly procure up to $5 million worth of medical and pharmaceutical products from Federal Supply Group 46 and Federal...
- This is a delivery order issued under a larger Indefinite Delivery Contract (IDC) held by Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc., with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at up to nearly $5 million, allows DLA to rapidly procure a range of medical and pharmaceutical products under Federal Supply Group 46 and Federal Supply Class 6515 to support military treatment facilities and other Department of Defense customers in DLA Region 1....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc. The contract has a ceiling value of $39,811.96 and was awarded on March 21, 2024 with an ultimate completion date of April 11, 2024. It is an Indefinite Delivery Contract (IDC) that allows DLA to rapidly procure a range of medical and pharmaceutical products, including surgical dressings, drugs, biologicals, and other medical consumables, to support...
- SPE2DV17D1012Indefinite Delivery Contract
- SPE2DV17D1012-SPE2DV22F69NKDelivery Order
This is a delivery order contract awarded to Cardinal Health 200, LLC by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The contract, valued at $3,162.17, is for the procurement of 4557446093 ! NDL ENT SEMIPERMANENT INJECTOR NI FR SM medical supplies. It is a firm fixed price Indefinite Delivery Contract (IDC) under which DLA can issue delivery orders to procure a range of medical and pharmaceutical products for military treatment facilities and other DoD customers in DLA Region 1. This IDC, worth up to nearly $5 million, was originally awarded in April 2024 and is set to run through August 2027. The contract does not have a set-aside designation.
Generated 7/11/24, 10:09 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 6/6/22 |